Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A meta-analysis of evidences on XPC polymorphisms and lung cancer susceptibility.
Liu C, Yin Q, Hu J, Li L, Zhang Y, Wang Y.
Tumour Biol. 2013 Apr;34(2):1205-13. doi: 10.1007/s13277-013-0663-9. Epub 2013 Feb 6.
Related citations
An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y, Wang X, Zhang W, Gong S.
Tumour Biol. 2013 Apr;34(2):973-82. doi: 10.1007/s13277-012-0633-7. Epub 2012 Dec 27.
Polymorphisms in XPC provide prognostic information in acute myeloid leukemia.
Xu P, Chen B, Feng J, Cheng L, Xia G, Li Y, Qian J, Ding J, Lu Z.
Int J Hematol. 2012 Oct;96(4):450-60. doi: 10.1007/s12185-012-1145-3. Epub 2012 Sep 12.
Deregulation of XPC and CypA by cyclosporin A: an immunosuppression-independent mechanism of skin carcinogenesis.
Han W, Soltani K, Ming M, He YY.
Cancer Prev Res (Phila). 2012 Sep;5(9):1155-62. doi: 10.1158/1940-6207.CAPR-12-0185-T. Epub 2012 Jul 30.
Poly (AT) polymorphism in the XPC gene and smoking enhance the risk of prostate cancer in a low-risk Chinese population.
Liu Y, Chen Z, Wei Q, Yuan F, Zhi Y, Song B, Yang J.
Cancer Genet. 2012 May;205(5):205-11. doi: 10.1016/j.cancergen.2012.01.013.
Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
Yang X, Liu D, Wu H, Kang H, Pang H, Huang D, Sha X, Wang E, Wang Z, Wei M.
Cancer Sci. 2012 Jul;103(7):1207-14. doi: 10.1111/j.1349-7006.2012.02312.x.
Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
Liu Y, Wang H, Lin T, Wei Q, Zhi Y, Yuan F, Song B, Yang J, Chen Z.
Oncol Rep. 2012 Jul;28(1):337-45. doi: 10.3892/or.2012.1759. Epub 2012 Apr 9.
Recognition of DNA damage by XPC coincides with disruption of the XPC-RAD23 complex.
Bergink S, Toussaint W, Luijsterburg MS, Dinant C, Alekseev S, Hoeijmakers JH, Dantuma NP, Houtsmuller AB, Vermeulen W.
J Cell Biol. 2012 Mar 19;196(6):681-8. doi: 10.1083/jcb.201107050.
DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D, Wu HZ, Zhang YN, Kang H, Sun MJ, Wang EH, Yang XL, Lian MQ, Yu ZJ, Zhao L, Olopade OI, Wei MJ.
Mol Carcinog. 2012 Oct;51 Suppl 1:E83-93. doi: 10.1002/mc.21862. Epub 2011 Dec 27.
Carrier frequency of the recurrent mutation c.1643_1644delTG in the XPC gene and birth prevalence of the xeroderma pigmentosum in Morocco.
Doubaj Y, Laarabi FZ, Elalaoui SC, Barkat A, Sefiani A.
J Dermatol. 2012 Apr;39(4):382-4. doi: 10.1111/j.1346-8138.2011.01453.x. Epub 2011 Dec 29.
Nucleotide excision repair factor XPC enhances DNA damage-induced apoptosis by downregulating the antiapoptotic short isoform of caspase-2.
Wang QE, Han C, Zhang B, Sabapathy K, Wani AA.
Cancer Res. 2012 Feb 1;72(3):666-75. doi: 10.1158/0008-5472.CAN-11-2774. Epub 2011 Dec 15.
XPC Lys939Gln polymorphism is associated with the decreased response to platinum based chemotherapy in advanced non-small-cell lung cancer.
Zhu XL, Sun XC, Chen BA, Sun N, Cheng HY, Li F, Zhang HM, Feng JF, Qin SK, Cheng L, Lu ZH.
Chin Med J (Engl). 2010 Dec;123(23):3427-32.
Genome-wide evidence of XPC alteration in laryngeal squamous cell carcinomas.
Yang M, Park JY, Tae K.
Asian Pac J Cancer Prev. 2011;12(6):1477-81.
The role of XPC: implications in cancer and oxidative DNA damage.
Melis JP, Luijten M, Mullenders LH, van Steeg H.
Mutat Res. 2011 Nov-Dec;728(3):107-17. doi: 10.1016/j.mrrev.2011.07.001. Epub 2011 Jul 7.
Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.
Qiao B, Scott GB, Elliott F, Vaslin L, Bentley J, Hall J, Bishop DT, Knowles MA, Kiltie AE.
BMC Med Genet. 2011 Jun 20;12:84. doi: 10.1186/1471-2350-12-84.
Differential contribution of XPC, RAD23A, RAD23B and CENTRIN 2 to the UV-response in human cells.
Renaud E, Miccoli L, Zacal N, Biard DS, Craescu CT, Rainbow AJ, Angulo JF.
DNA Repair (Amst). 2011 Aug 15;10(8):835-47. doi: 10.1016/j.dnarep.2011.05.003. Epub 2011 Jun 14.
Fission yeast homologs of human XPC and CSB, rhp41 and rhp26, are involved in transcription-coupled repair of methyl methanesulfonate-induced DNA damage.
Kanamitsu K, Ikeda S.
Genes Genet Syst. 2011;86(2):83-91.
The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.
Gil J, Ramsey D, Stembalska A, Karpinski P, Pesz KA, Laczmanska I, Leszczynski P, Grzebieniak Z, Sasiadek MM.
Mol Biol Rep. 2012 Jan;39(1):527-34. doi: 10.1007/s11033-011-0767-5. Epub 2011 May 11.
Association of XPC polymorphisms with breast cancer risk.
Xu F, Zhong D, Tang Z, Zhou M, Zhu Y.
Breast Cancer Res Treat. 2011 Sep;129(2):655-7. doi: 10.1007/s10549-011-1550-y. Epub 2011 May 8. No abstract available.
Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer.
Xu XS, Wang L, Abrams J, Wang G.
J Hematol Oncol. 2011 Apr 20;4:17. doi: 10.1186/1756-8722-4-17.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on